ABSTRACT
INTRODUCTION
Gestational diabetes mellitus (GDM) is a metabolic disorder and a common medical complication during pregnancy. GDM is associated with adverse fetal and maternal outcomes that can be prevented by timely diagnosis and management of GDM (1) . Routine screening for GDM is therefore an important acceptable sensitivity and specificity (6, 7) . On the other hand, fasting blood glucose (FBG) (8) and random blood glucose (RBG) (9, 10) are the simplest and commonly used tests for the (pre)screening of GDM.
Measurement of glycated proteins including fructosamine (11) and glycated hemoglobin (HbA1c) (12) has been employed for the assessment of short-and long-term glycemic control, respectively. Determination of serum fructosamine is a fullyautomated, simple, sensitive and reproducible method for the evaluation of glycemic control (13) . Since fructosamine determines the average glucose over the past 2-3 weeks the test is not affected by the food eaten during the day. Serum fructosamine levels did not differ significantly if measured at fasting or 2 h after ingestion of 75 g glucose (14) . For this reason fructosamine can be measured at any time during the day. The use of serum fructosamine for the screening of GDM has been widely reported (15) (16) (17) (18) (19) . A single fructosamine test compared to GCT has given a sensitivity of 87.5% and specificity of 94.5% for the detection of GDM (20) . Salemans et al (21) have noticed that fructosamine is more sensitive than HbA1c for the detection of abnormal glucose tolerance. Serum fructosamine has been correlated with FBG (22, 23) , OGTT (18) and HbA1c (16) . This investigation was aimed to find out a possible association between serum fructosamine and FBG or RBG, and the usefulness of the paired values of fructosamine with FBG or RBG for filtering the high risk patient towards screening the GDM.
MATERIALS AND METHODS
A total of 165 Saudi pregnant women attending the antenatal care clinics at the Armed Forces Hospital, Riyadh during the years 2003-2004 were included in this study. Venous blood samples were collected from all the subjects after at least 8 h fasting for the analysis of FBG, whereas the blood samples from the non-fasted subjects were collected for the analysis of RBG and serum fructosamine.
All the three biochemical parameter were analyzed by using an Autoanalyzer (Roche Modular P-800, Germany). The actual fructosamine levels were corrected for serum protein to give corrected-fructosamine (cFruct) for more precise presentation (22, 24, 25) . Two cut-off values of FBG (>5.3 mmol/L and >7.0 mmol/L) and RBG (>7.8 mmol/L and >11.0 mmol/L) were used to classify hyperglycemic subjects. A reference range of cFruct between 1.8 -2.5 mmol/L was used on the basis of earlier reports (13, 19) .
The data were evaluated by SPSS statistical package version 10. Pearson's correlation test was performed to analyze an association between c-Fruct and FBG or RBG. Independent samples Student's t-test (2-tailed) was used to compare means between the normal and hyperglycemic groups, categorized using specified criteria. P values less than 0.05 were considered as statistically significant. 
RESULTS
The levels of FBG, RBG and c-Fruct in 165 pregnant women were found to be 5.865 mmol/L, 7.767 mmol/L and 2.387 mmol/L respectively ( Table 1 were also significantly correlated with cFruct ( Fig. 1 ).
Using the FBG cut-off >5.3 mmol/L, 81 subjects were classified as hyperglycemic; this frequency reduced to 24 subjects when a FBG cut-off >7.0 mmol/L was used (Table 2) . However, among these 24 subjects (who had FBG > 7.0 mmol/L), 5 patients had incompatible RBG (d 7.8 mmol/L) or cFruct (d 2.5 mmol/L) levels. Using the RBG cut-off >7.8 mmol/L, 62 subjects were classified as hyperglycemic, whereas a high the cut-off value of RBG > 11 mmol/L reduced the number of hyperglycemic subjects to 24 ( Table 2) . Of these 24 subjects, 7 subjects showed incompatible FBG (d 5.3 mmol/L) or cFruct (d 2.5 mmol/L) levels. The levels of FBG, RBG and cFruct were significantly higher in hyperglycemic groups (irrespective of grouping criteria) as compared to the respective normal groups ( Table 2) . (Fig.  2a) . On the other hand, using the combination of RBG > 7.8 mmol/L and cFruct > 2.5 mmol/L, 32 patients were categorized as hyperglycemic while 5 subjects each appeared to be falsepositive (3.0%) and false-negative (3.0%) (Fig. 2b) . Twenty seven (84.4%) of these 32 patients were common to the filtered patients while using the FBG plus cFruct criteria. 
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DISCUSSION
Our results showed a significant correlation between FBG and RBG levels. The criteria of FBG >7.0 mmol/L resulted 24 subjects to be hyperglycemic (Table 2) ; of these 24 patients, 3 patients had incompatible RBG (d 7.8 mmol/L) and cFruct (d 2.5 mmol/L) whereas 2 patients each had incompatible RBG or cFruct levels. Similarly, the use of RBG >11.0 mmol/L assigned 24 subjects with hyperglycemia ( Table 2) patients to be hyperglycemic the identity of these patients was not common with each criteria suggesting the poor efficiency of these tests. Although FBG is a simplest and commonly used screening test for GDM (26) its poor performance should not be ignored (27) (28) (29) . Larsson et al (29) have suggested that a single FBG is not useful for screening of diabetes. They observed that reducing the FBG cut-off value from 6.0 mmol/ L to 4.8 mmol/L increased the sensitivity from 53.4% to 85.9% at the expense of poor specificity (45%) (29) . Lowering the threshold value of FBG to 4.4 mmol/L did not miss any case of GDM (100% sensitivity) but with very low specificity and a very high percentage (55%) of false-positive results (30) . Recently, a FBG threshold of 4.7 mmol/L reached the minimal acceptable sensitivity of 78.1% with a corresponding unacceptable specificity of 32.2% (31) . Several investigators have also reported the use of RBG for short-listing patients for OGTT (32, 33) . However, RBG alone cannot be considered as an efficient screening test for the detection of GDM (6,7). According to Bhattacharya (27) , both FBG and RBG alone cannot be regarded as efficient screening tests for GDM, particularly in the later months of pregnancy.
A significant correlation was observed between FBG and cFruct ( Fig. 2a) which is in accordance with earlier studies (13, 22, 23) . RBG also showed significant correlation with cFruct (Fig. 2b ). Significant correlations between serum fructosamine and preprandial (17) or postprandial (24) blood glucose levels have been reported earlier. Both FBG and RBG reflect the instant blood glucose level without predicting a time-course glycemic history. Whereas, serum fructosamine is a simple, sensitive and precise method for the evaluation of glycemic control within a few weeks time (2-3 weeks) and is therefore more advantageous in timely detection of responses to diabetic treatment plan (11) . However, fructosamine assay is associated with poor sensitivity and specificity for diagnostic purpose (34) . Bor et al (35) observed that fructosamine alone has low sensitivity as predictor of GDM and therefore cannot be recommended for screening of GDM.
On the other hand, use of paired values of cFruct and FBG or RBG instead of their individual performance could be a sensitive and safe strategy to filter high-risk patients while avoiding OGTTs in the remaining large number of normal cases. The combination of a moderate cut-off value of FBG (> 5.3 mmol/L) with cFruct (> 2.5 mmol/L) identified 35 high risk patients on whom a confirmatory OGTT could be performed (Fig. 2a) . However, this strategy was associated with 8 (4.8%) false-positive and 6 (3.6%) false-negative outcomes. On the other hand, combination of RBG > 7.8 mmol/ L with cFruct > 2.5 mmol/L filtered 32 high-risk patients with 5 (3.0%) each of false-positive and false-negative predictions (Fig. 2b) . The individual performance of these tests for filtering hyperglycemic subjects using the above respective cut-off value was as follows: FBG alone (81 subjects), RBG alone (62 subjects) and cFruct alone (42 subjects). Various cut-off values of both FBG (29, 31, 36) and serum fructosamine (23, 36, 37) have been used to maintain a balance between false-positive and false-negative results. Agarwal and Punnose (25) pointed out that FBG alone can eliminate the need for 57.8% OGTTs by using the cut-off values of FBG t 5.3 mmol/ L to rule-in GDM and FBG < 4.4 mmol/L to rule-out GDM. However, if FBG is used in conjunction with cFruct, additional 10.4% patients would not need OGTT (25) . It is clear from the above studies that the sensitivity can be increased using high cut-off values but with a corresponding decrease in the specificity.
In conclusion, the paired values of cFruct with FBG or RBG could be utilized in avoiding unnecessary OGTT in a large number of cases as suggested earlier (25, 31, 36, 37) . Moreover, since the cFruct is a reliable test for understanding the shortterm glycemic history the strategy of paired values can also be utilized for the subsequent monitoring of GDM.
